Inhibition of DAGLbeta as a therapeutic target for pain in sickle cell disease. Khasabova IA, Gable J, Johns M, Khasabov SG, et al. Haematologica 2023;108:859-869.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Khasabova IA, Gable J, Johns M, Khasabov SG, et al. Inhibition of DAGLbeta as a therapeutic target for pain in sickle cell disease. Haematologica 2023;108:859-869.
PMID: 35615929